Keith Chog

StratifiCare is a Singaporean company that specializes in the development and manufacturing of IVD assay solutions for personalized medicine. The company is based in Singapore, SG, and has subsidiaries in the United States. With over 50 years of cumulative experience in Biomedical R&D and technology commercialization, StratifiCare is working on a new Point-of-Care Platform to transform the way patients are managed through personalized care. The company was founded in 2015 with the aim of empowering personalized medicine through innovative diagnostic solutions. Anthony Chua founded the company in 2015 and has been the CEO since then.